youtube_live
Q3 2026 earnings • released • EPS met 0.00% • Revenue beat +65.05%
See resultschevron_right
MOC:WSE
Molecure SA
PLNÂ 5.40
arrow_downward
-4.93%(-0.28) 1D
Nov 3, 3:41:16 PM GMT+1 · PLN
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOC...
Open
PLNÂ 5.67
High
PLNÂ 5.70
Low
PLNÂ 5.35
Mkt. cap
133.51M
Avg. vol.
42.72K
Volume
26.50K
52-wk high
PLNÂ 9.04
52-wk low
PLNÂ 4.98
EPS
-PLNÂ 0.64
Shares outstanding
24.72M
No. of employees
45
Open
PLNÂ 5.67
High
PLNÂ 5.70
Low
PLNÂ 5.35
Mkt. cap
133.51M
Avg. vol.
42.72K
Volume
26.50K
52-wk high
PLNÂ 9.04
52-wk low
PLNÂ 4.98
EPS
-PLNÂ 0.64
Shares outstanding
24.72M
No. of employees
45
News stories
From web sources and news partners
Investing.com
·
40 minutes ago
MediWound’s EscharEx Strategy May Be Ahead of the Game as FDA Puts Chronic Wounds in Focus (Nasdaq: MDWD)
www.marketscreener.com
·
1 hour ago
NYSE-Affiliated Venue for Tokenization Adds Transfer Agents: NYSE Content Update
Seeking Alpha
·
5 minutes ago
Most shorted stocks on Wall Street
Barchart.com
·
2 hours ago
Upstart (NASDAQ:UPST) posts better-than-expected sales in Q3 2026, stock soars
About Molecure SA
CEOMarcin Jan Szumowski
Employees45
Founded2012
Headquarters-
SectorPharmaceutical industry
Websitemolecure.com